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Abstract The importance of salt restriction in the treatment
of patients with renal disease has remained highly contro-
versial. In the following we marshal the current evidence
that salt plays a definite role in the genesis of hypertension
and target organ damage, point to practical problems of salt
restriction, and report on novel pathomechanisms of how
salt affects blood pressure and causes target organ damage.
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Salt and blood pressure
Adults
In a crucial experiment, Denton et al. [1] measured the
blood pressure of chimpanzees on a salt-enriched diet
and control chimpanzees on a no-added salt diet. After
6 months in chimpanzees on a salt enriched diet blood
pressure had increased in chimpanzees on a salt-enriched
diet, from 110 mmHg systolic to 145 mmHg, while it had
not changed in the control group. The effect was fully
reversible after the high salt diet was stopped. Meanwhile,
the Dietary Approaches to Stop Hypertension (DASH)
study provided convincing evidence that a diet with
reduced salt (NaCl) intake [but also additional dietary
manipulation, particularly higher potassium (K) intake]
decreased systolic blood pressure: when sodium (Na) intake
was reduced from 150 mmol/day to 50 mmol/day, systolic
blood pressure (office blood pressure) decreased by
6.7 mmHg in the overall cohort, and, in hypertensive indi-
viduals, even by 11 mmHg [2]. This may even have been
an underestimate. Using the more sensitive ambulatory
blood pressure measurement, a double-blind placebo-
controlled crossover trial recently showed that reduction
of salt intake by 50 mmol/day from 150 mmol/day to
100 mmol/day lowered 24 h blood pressure by no less than
5.7 mmHg systolic and by 6.3 mmHg at night time [3].
The change in blood pressure with salt restriction is
particularly marked in patients with renal failure [4], and
this parallels the observation of an exaggerated blood
pressure increase in animals on a high salt intake that was
characterized by reduced numbers of nephrons [5].
Children, programming and salt sensitivity
of blood pressure
More than 20 observational studies on salt and blood
pressure in children were reviewed by Simons-Morton and
Obarzanek in 1997 [6]. The majority of studies showed a
significant positive association between salt intake and
blood pressure. In the study by Cooper and Liu [7]a
significant linear relationship between urinary sodium and
blood pressure in 73 children aged 11 years to 14 years was
noticed after the authors had controlled for age, gender,
race, pulse rate, height and body weight. The same result
Pediatr Nephrol (2009) 24:9–17
DOI 10.1007/s00467-008-0856-4
“Public Health would benefit more by applying what is known already
than from scientific breakthroughs.” Lord Rosenheim (1908–1972)
E. Ritz (*)
Department of Internal Medicine,
Ruperto Carola University of Heidelberg, Nierenzentrum,
Im Neuenheimer Feld 162,
69120 Heidelberg, Germany
e-mail: prof.e.ritz@t-online.de
O. Mehls
Division of Pediatric Nephrology,
University Children’s Hospital of Heidelberg,
Heidelberg, Germanywas noticed in 233 Dutch children aged 5 years to 17 years
and followed up for ≥7 years [8]. A meta-analysis of ten
controlled trials with 966 children and adolescents was
reported by He and MacGregor [9]. Mean salt intake was
reduced by 42%, and the median duration was 4 weeks,
rangingfrom2weeks to3years.Bothsystolic(−1.17mmHg)
and diastolic (−1.29 mmHg) blood pressures were signifi-
cantly decreased. In three trials on infants, including 541
participants, salt intake was reduced by 54% and the systolic
blood pressure by 2.47 mm Hg. The authors concluded that
neonatal salt intake may induce blood pressure tracking and
late hypertension.
Many experimental studies have documented that the
fetal environment, including salt intake of mothers, can
have long-lasting effects on blood pressure, but salt intake
was not studied as an independent factor.
Exposure of mothers to low or high salt throughout
gestation had a long-lasting impact on salt preference of
offspring [10, 11]. In the study by Ross et al. lambs were
exposed to in utero hypernatremia induced by maternal
water restriction [12]. Offspring of prenatally water-restricted
mothers exhibited hypernatremia, hypertonicity and hyper-
tension. Thus, maternal nutrient stress may program altered
osmoregulation and systemic arterial hypertension in the
offspring. Interestingly, Crystal and Bernstein [13]d e m o n -
strated that infants of mothers who had suffered morning
sickness during early pregnancy drank more concentrated
salt solutions than controls. In young students whose
mothers reported morning sickness, Málaga et al. also found
a greater preference for salty food [14]. In infants and young
children, salt taste preference was inversely related to birth
weight over the first 4 years of life [15].
Thus, the early response to salty tasting food might
predict future sodium intake and blood pressure.
Porter et al. [16] were the first to investigate whether high
salt intake in the mother programmed blood pressure and
heart rate hyper-responsiveness to stress in adult offspring
independently of birth weight. A high sodium diet admin-
istered to pregnant rats during the perinatal period was not
sufficient to program lasting hypertension (measured by
telemetry) or salt sensitivity of blood pressure in offspring.
However, enhanced pressure and tachycardiac response to
acute stress persisted into adulthood. This was accompanied
by increased mRNA expression of corticotrophin-releasing
hormone under basal and stress conditions. The programmed
defects did not depend on birth weight and might have
involved other mechanisms, for instance augmented activa-
tion of the sympathetic nervous system.
According to the Borst–Gyton concept, chronic hyperten-
sion occurs only with a shift in the renal pressure–natriuresis
relationship, resulting in increased salt sensitivity of blood
pressure. Birth weight was negatively associated with salt
sensitivity of blood pressure, and this was independent of the
association between birth weight and glomerular filtration
rate (GFR) [17]. Kidney and central nervous system seem to
be the major sites for salt sensing: by chloride sensing in
renal tubule fluids via sodium–potassium–chloride (Na-K-
Cl) co-transporter isoforms in the macula densa cells; by
sodium sensing in cerebrospinal fluid; by the sensing of
cerebrospinal fluid osmolarity by mechanosensitive, non-
selected cation channels, and by osmolarity sensing in glial
cells [18]. The plurality of salt-sensing mechanisms allows
very precise control of blood pressure. Modifications of
sensor programming or of feedback signaling are strong
candidates for the programming of blood pressure and salt
sensitivity. Other options for the development of salt-
sensitive hypertension are genetic and congenital factors,
which might predispose individuals to microvascular disease;
interstitialdamage;localangiotensinIIformation,andoxidant
generation [19].
Effects of salt intake on cardiovascular and other endpoints
Apart from the effect of salt intake on blood pressure, its
effect on cardiovascular endpoints is of interest as well. A
recent meta-analysis showed by extrapolation that, in the
general population, reduction of salt intake by 3 g/day, and
the resulting decrease in blood pressure, would translate
into a 13% reduction in stroke and a 10% reduction in
ischemic heart disease events [9]. An observational study
from Finland even suggested that a 100 mmol difference in
salt intake would reduce the relative risk of coronary heart
disease by 50%, independent of blood pressure [20].
Apart from these observational studies, there is only one
series of two small prospective but long-term (10–15 years)
studies available in which salt intake was reduced by
44 mmol/day and 33 mmol/day, respectively. These Trials
of Hypertension Prevention (TOPH) I and TOPH II studies
document a significant impact of moderate salt reduction on
cardiovascular endpoints by 25%. There was even a trend
for reduction of mortality by 20% [21].
Apart from the information on cardiovascular events,
limited information is also available on the effect of high
salt intake on renal parameters. Salt load increases the local
concentration of angiotensin II in the kidney, thus con-
stricting the efferent vessels of the glomeruli followed by
an increase in intraglomerular pressure and filtration [19].
Verhave et al. [22] observed that urine albumin excretion in
the general population was correlated with the magnitude of
sodium excretion; this correlation was most marked in
individuals in the highest tertile of the body mass index. A
correlation between salt intake and albuminuria has also
been found in the rat uninephrectomy model [23] and in the
Munich Wistar rat with spontaneously reduced nephron
numbers [5]. Albumin excretion rates were also higher in
rats with intra-uterine growth retardation [24].
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salt intake in rats with renal injury. Dworkin et al. [25] kept
subtotally nephrectomized rats for 4 weeks on standard
chow and subsequently randomly allocated them either to
low salt chow or standard chow. A reduction in proteinuria
was observed in the rats on the low-salt chow and
progression in rats on standard chow; this was accompanied
by a further increase in the proportion of sclerotic glomeruli
in the latter group.
Salt loading also promotes renal fibrosis in numerous,
but not all, models of renal damage [26, 27]. Of particular
interest is the observation that the effect of salt restriction
cannot be reproduced by the administration of a diuretic
[28].
Mechanisms of salt-induced target organ damage
In patients with chronic kidney disease a high salt intake
may be “nephrotoxic” by indirect mechanisms, e.g. by an
increase in blood pressure and by attenuation of the
pharmacologic blockade of the renin–angiotensin system
blunting its anti-hypertensive and anti-proteinuric effect.
The latter was elegantly documented when patients with
nephrotic proteinuria were treated with lisinopril: the anti-
proteinuric effect was markedly reduced by a high-salt diet
[29]. In patients with chronic kidney disease, salt loading
increases renovascular resistance, with the attendant decrease
in renal plasma flow, and increases glomerular capillary
pressure as extrapolated fromthe increase infiltration fraction
[30], effects certainly undesirable in patients with chronic
kidney disease.
One main pathomechanism underlying salt-induced
tissue damage is oxidative stress, a phylogenetically ancient
reaction: when plants, such as marigold, grow in an
environment with high salinity, oxidative stress occurs and
leads to stunted growth [31]. Similarly, high salt intake
increases oxidative stress in the mammalian kidney by a
combination of increased generation and decreased break-
down of reactive oxygen species (ROS) [32]: the expression
of reduced nicotinamide adenine dinucleotide phosphate
[NADPH] oxidase mRNA is increased 2–3 fold, whilst the
expression of several isoforms of superoxide dismutase is
reduced. Increased oxidative stress in the animals on high-
salt diets is proven by the decreased urinary excretion of 8-
isoprostane, a lipid marker of oxidative stress [32].
High salt intake presumably causes hypervolemia,
increases blood flow and shear stress in central arterial
vessels and induces expression of endothelial nitric oxide
(NO) synthase (eNOS) [33]. In the kidney as well, Sato et
al. [34] documented that expression of eNOS mRNA is
modulated by salt intake. In the Thy1 glomerulonephritis
model this was paralleled by changes in the expression of
transforming growth factor beta (TGF-β)[ 35].
The right balance between too little and too much salt
Currently there is an animated discussion as to whether
reduction of salt intake might have negative consequences.
It goes without saying that radical salt restriction causes
hypovolemia, with the attendant adverse effects, e.g.
reduced resistance against circulatory shock and possibly
also predisposition to acute renal failure. Extremely low salt
intake also causes more long-term adverse effects, such as
acceleration of atherosclerosis, as shown in a genetic model
of atherosclerosis, the apoE−/−mouse [36]: a low-salt diet
stimulated the renin–angiotensin system and increased the
size of atherosclerotic plaques in the aorta. It is also of
interest that, in pregnant rats, an extremely low salt intake
(0.03%) causes intrauterine growth restriction and adult
hypertension in the offspring [37].
The explanation of why both too high and too low a salt
intake cause adverse effects is the fact that high salt intake
induces inhibitors of the Na
+K
+ pump (cardiotonic steroids)
on the one hand [38], whilst low salt intake up-regulates the
activity of the renin–angiotensin system, increases angio-
tensin II, and up-regulates NADPH oxidase, thus generating
reactive oxidant species [39]( F i g .1).
A sound balance between these two extremes is struck
by current guidelines [40], which recommend for adults a
reduction in the usual daily sodium intake to 80–100 mmol,
corresponding to an intake of 4.7–5.8 g salt.
What evidence is available in children?
In children, two controlled trials were performed in free-
living individuals in whom urinary sodium output was
ROS
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Fig. 1 Both too high and too low a salt intake produce ROS and
oxidative end products
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mean intake of 133 mmol sodium per day (7.8 g salt) [41].
In 13-year-old boys the mean intake was 150 mmol per day,
and in girls it was 142 mmol per day (corresponding to
8.8 g and 8.4 g salt, respectively) [42]. In 4–6 year-old
children the average urinary sodium was 64 mmol per day,
corresponding to 3.8 g salt [43]. The National Diet and
Nutrition Survey for young people, which was carried out
in Great Britain in 1997, investigated 1,658 participants
aged between 4 years and 18 years regarding their salt intake
and blood pressure. The mean salt intake was 4.7 g/day at the
age of 4 years, and it increased with age to 6.8 g/day at the
age of 18 years. After adjustment for age, gender, body mass
index and dietary potassium, an increase of 1 g salt per day
was related to an increase of 0.4 mmHg systolic pressure and
0.6 mmHg pulse pressure [44]. In children the proportion of
food that children consumed in restaurants and food outlets
increased by 300% between 1977 and 1996 [45]. In the
Finish Special Turku Coronary Risk Factor Intervention
Project (STRIP), children had exceeded the estimated
requirements of the US National Academy of Science by
about 700% at 13 months, 3 years and 5 years of age [46].
For children no data exist on the physiological ranges
required for sodium homeostasis. Therefore, the recommen-
dations for sodium intake in infants are based on the upper
end of the breast milk reference intake range, whereas, for
older children, the recommendations are estimated facto-
rially by calculation of daily increments in total body sodium
content, allowing for changing body composition and
compartmentation, such as the declining proportion with
age of extracellular fluid in body mass and for dermal, fecal
and some urinary losses. According to the dietary recom-
mendations of the Scientific Advisory Committee on
Nutrition, the estimated minimum requirements of sodium
for 1-year-old children is 225 mg sodium/day (0.6 g NaCl),
and for 2–5 year-old children it is 300 mg/day (0.8 g NaCl)
[47]. The British reference nutrient intakes (RNIs) for
sodium and target average salt intake are given in Table 1.
These values have been estimated on the same basis used to
derive the recommended target salt intake for adults, i.e. an
increase in the RNI by a factor of 1.5. There is insufficient
evidence to define precisely the upper limits of salt intake
in relation to cardiovascular risk in children.
An unresolved issue remains about how patients can
manage to achieve reduction of their salt intake from the
current 12–14 g/day for adults to the above recommended
level. Unfortunately, according to Sanchez-Castillo [48],
table salt contributes only 10% to the daily dietary intake,
and no more than 5% is contributed by salt added during
cooking—both sources can be directly controlled by
patients. In contrast, 85% of salt is latent, added by the
food industry and therefore contained in the food items
used for cooking. As a result, the recommended moderate
reduction of salt intake is difficult to achieve. The best
strategy is a community approach involving health policy
actions to motivate the food industry to reduce the salt
content of food items. This is in line with the American
Public Health Association resolution, which postulates that
food manufacturers and restaurants should reduce sodium
in the food supply by 50% during the next decade [49]. We
realize that this is a hot political issue, which has provoked
an intense political debate [50].
It has been suggested that, apart from this political
resistance against the reduction of salt intake, latent historical
reminiscences may charge the issue emotionally [51].
Resistance to salt restriction—historical reminiscences
As shown in Fig. 2, salt intake in the era of hunters and
gatherers was very low, presumably less than 1 g per day. It
was only during the agricultural revolution and the
associated population growth that higher salt intake became
a necessity. The current high levels of salt intake, however,
Table 1 Reference nutrient intakes (RNIs) for sodium and target
average salt intake for infants and children
Age (years) RNI Target average
intake (g/day)
Sodium mmol/day
(mg/day)
salt (g/day)
0–0.5 8 (184) 0.5 < 1
0.5–1 12 (276) 0.7 1
1–6 26 (598) 1.6 2
7–14 60 (1,380) 3.6 5
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Fig. 2 Increase of salt intake during evolution. Courtesy of Dr. P.
Ferrari, Department of Nephrology, Fremantle Hospital, Perth,
Western Australia, Australia
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of commerce.
As emphasized by several authors, the history of salt as a
scarceproductofvitalimportanceforsurvivalleftpresumably
historical reminiscences which perpetuate the notion that salt
is a valuable essential constituent of the diet [52]. In many
cultures around the world, salt, a white substance, is a symbol
of the immaculate, the incorruptible, the imperishable, as
reflected by the Arabian proverb “Salt is not worm eaten”.I t
has been an emblem of immortality and a symbol of
immutable loyalty, as reflected by the sharing of bread and
saltwith a guest, a customstill alive in Slavic countries. Inthe
past, ratifying contracts and sealing covenants included the
use of salt, as reflected by the quotations in the Bible “It is a
covenant of salt forever, before the Lord” (Numbers 18: 19)
and “The Lord God of Israel gave the Kingdom over Israel to
David forever, even tohim and his sons by a covenant of salt”
(2 Chronicles 13: 5). Paradoxically from today’s perspective,
in ancient Rome saltwas even regarded as a symbolof health.
This concept is still reflected by the words salus (health) and
salubris (healthy) in Latin and the greeting “salut” in French.
Officials and soldiers in ancient Rome did not receive money,
but a fixed amount of salt (salarium) which is still reflected in
the modern words salary (English), salaire (French), sold and
soldier (English). Salt had enormous economic value, akin to
gasoline today, and this explains why salt production was so
important economically that the names of many cities still
reflect past salt production: the syllable “wich”,p o i n t i n gt oa n
ancient saltern, is retained in names such as Sandwich,
Ipswich; the Celtic word Hall for salt is still preserved in
names such as Hall/Tirol, Halle/Saale; the Germanic words
Salz and Salt are still preserved in names such as Salzburg,
Langensalza and Saltcotes.
As a final remark, the salt tax was a major cause that
sparked the French Revolution. Like the gasoline tax today,
salt was an indispensable commodity and, for the authorities,
an ideal object for taxation. This invited salt smuggling in
pre-revolutionary France, which a special salt police (les
gabelous) tried to suppress. They carried out military actions
against salt smuggling, searched private property for hidden
salt, and, notoriously, molested women (who were, however,
frequently hiding smuggled salt in their underwear). The
degree of oppression is reflected by the fact that, in the last
year before the French Revolution, 3,500 citizens were
sentenced to death or the galleys because of salt smuggling.
This explains why, in the French Revolution, all salt tax
officials were decapitated.
The importance of salt balance on hemodialysis
When maintenance hemodialysis was introduced by Belding
Scribner and colleagues in March 1960, they wrote 6 weeks
later in their famous preliminary report [53] “as in the case
of nephrectomized dogs, hypertension appears to be influ-
enced by the size of the extracellular space. The combination
of dietary sodium restriction and ultrafiltration during
dialysis permits the regulation of extracellular volume”.T o
his last days Scribner emphasized the method of drug-free
salt restriction and ultrafiltration to control blood pressure
[54]. The high efficiency of a negative salt balance in
controlling blood pressure of patients on dialysis was
confirmed by numerous others. The original concept that
the adverse effect of sodium was mediated exclusively via
hypervolemia, as originally suggested by Guyton et al. [55],
must, to some extent, be modified, however, in the light of
some recent observations by Titze and co-workers [56], who
showed that sodium can be stored in the skin and other
organs in an osmotically inactive form. It is currently
unknown whether this mechanism has repercussions on the
blood pressure effect of a positive salt balance in humans.
An attractive alternative hypothesis is that salt induced
hypertension is the consequence of salt induced cardiotonic
steroids (see below).
Obviously, hypervolemia per se does not necessarily
raise blood pressure, as exemplified by the observation of
low blood pressure in pregnancy, despite hypervolemia.
Hypertension occurs only when the vascular resistance is
inappropriately elevated (Table 2).
Only a few centers, e.g. Tassin, in France [57], stuck to a
rigorous low-salt diet and use of lower concentrations of
sodium in the dialysate as proposed by Scribner. This
strategy reduces extracellular volume and total peripheral
resistance, yet, it is at the expense of increased norepi-
nephrine and angiotensin II concentrations. Nevertheless,
normal blood pressure values are achieved in the vast
majority of patients. This is not explained by the prolonged
dialysis times at the Tassin center, since similar blood
pressure lowering by dietary salt restriction, ultrafiltration
and reduction of dialysate sodium was also achieved in
patients with dialyses of 5 h duration [58]. By reducing salt
intake and by aggressive ultrafiltration, Ozkahya [59] even
achieved regression of left ventricular hypertrophy without
the use of anti-hypertensive drugs. That such a regime
might require blockade of the counter-regulatory increase
Table 2 Causes of inappropriately high vascular resistance in uremia
Cause
Activated renin–angiotensin system
Stimulated sympathetic nerve activity
Reduced breakdown of catecholamines (renalase)
Oxidative stress
Reduced endothelial cell-dependent dilatation (ROS)
Vascular remodeling with structurally fixed elevation of vascular resistance
Pediatr Nephrol (2009) 24:9–17 13of the renin–angiotensin system (RAS) (and possibly also
of the sympathetic nerve system) was shown by Tycho
Vuurmans and colleagues [60]. They studied pulse wave
velocity as an index of vascular stiffness: this parameter was
not changed by administration of angiotensin-converting
enzyme (ACE) inhibitors or by volume removal, yet it was
normalized by the combination of the two maneuvers.
One further mechanism for how positive salt balance and
hypervolemia may have adverse effects is the ‘intestinal
leak’ of endotoxin resulting from edema of the intestinal
mucosa. In edematous patients with heart failure Niebauer et
al. [61] showed that transit of bacterial lipopolysaccharide
across the intestinal mucosa and signs of micro-inflammation
were reduced when the edema of the intestinal mucosa was
reduced by diuretic treatment.
Pathomechanisms underlying salt-induced target
organ damage: cardiotonic steroids
Ever since Sir William Withering noted the therapeutic
efficacy of foxglove in edematous patients with heart
disease (“An Account of the Foxglove and some of its
Medical Uses”, 1789) it had been suspected that digitalis
acted as a substitute for an endogenous mammalian digitalis
compound. The search for such a compound, however, was
futile for a long time because of methodological limitations.
Mammalian endogenous inhibitors of Na
+,K
+ adenosine
triphosphatase (ATPase) were found decades ago, but only
recent methodological breakthroughs have permitted us to
identify cardenoloids (ouabain, digoxin) and bufadienolides
(marinobufagenin), i.e. substances which have marked
effects on blood pressure, natriuresis and other functions
[38]. Marinobufagenin, which was originally found in the
skin of toads, is natriuretic [62]. Its blood concentration
varies with changes in environmental salinity [63]; it causes
vasoconstriction in the mammalian organism [64], and its
concentration increases after volume expansion [65] as well
as in pathological states of volume expansion, e.g. uremia
and pre-eclampsia [64, 66].
The ideas concerning the mode of action of these
compounds have recently undergone a transformation. In
the past it had been assumed that these inhibitors of sodium
potassium ATPase are inotropic in the heart because of an
increase in intracellular calcium (Ca
++) resulting from
accumulation of intracellular sodium and backward running
of the Na
+Ca
++ exchanger. More recently, however, it has
been found that they act as signal transducers at nanomolar
or sub-nanomolar concentrations which do not inhibit the
Na
+,K
+-ATPase: they bind to the extracellular domain of
the α-1 chain of Na
+,K
+-ATPase, cause slow Ca
++
oscillations by interaction with the endoplasmic reticulum
(Fig. 3a), generate reactive oxygen species by acting on the
mitochondria (via src, epidermal growth factor receptor
(EGF-R), ras, raf, MEK) (Fig. 3b) and activate nuclear gene
programs [67], mainly as the result of the activation of
nuclear factor-kappa B (NFκB) by the slow calcium
oscillations (Fig. 3c).
The signaling is mediated by interaction of the N-terminus
of Na
+,K
+-ATPase with cardiotonic steroids, creating a so-
called signalosome. Such signaling influences cell prolifera-
ouabain + Na+K+ATP‘ase
endoplasmic
reticulum
cytosolic Ca++ 
NF
KB
cell
proliferation
anti-
apoptosis
Na+
Na+K
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Fig. 3 Signaling pathways of cardiotonic steroids a Activation of
NFκB via slow Ca
++ oscillations following modification of Ca
++
release from endoplasmic reticulum. b Activation of mitochondrial
ROS via src and EGF-R. c Activation of nuclear gene programs via
scr and EGF-R. PKC protein kinase C
14 Pediatr Nephrol (2009) 24:9–17tion (apoptosis) and cell–cell contact (cell migration)—this
has led to the development of anti-cancer agents. In the
kidney, the effect of inhibiting apoptosis and stimulating cell
proliferation via activating NFκB has been well documented
[68]. Such signaling also modulates natriuresis and blood
pressure—this even led to the development of novel anti-
hypertensive substances [69].
With respect to uremia, it is of considerable interest that,
in subtotally nephrectomized rats, endogenous marinobufa-
genin concentrations are increased [70]. If similar concen-
trations were achieved by infusing marinobufagenin in rats
subjected to sham operation, cardiac hypertrophy with
thickening of the left ventricular wall, cardiac fibrosis,
diastolic malfunction and signaling via Src/ERK were
observed. All these adverse effects could be prevented by
pre-immunization, yielding neutralizing antibodies against
marinobufagenin.Indialysispatientsacorrelationwasfound
between endogenous ouabain by radio-immunosorbent
assay (RIA) and mass spectrometry and left ventricular
(LV) mass, LV volume and eccentric LV hypertrophy [71].
It is likely that, apart from in the heart, cardiotonic
steroids play a role in the genesis of other types of uremia-
induced target organ damage as well.
Conclusion
There is strong evidence that salt intake plays an important
role in the genesis of hypertension and target organ
damage. Both high and low sodium intake cause adverse
effects. The average salt intake of healthy children and
adults exceeds, by far, the recommendations of current
guidelines. The sodium content of most commercially
available food items is too high, and this accounts for nearly
three-quarters of salt intake. The most important aspect of
strategies to reduce salt intake is an effort to make the food
industry reduce nutrient salt content. Especially in renal
patients, diuretics are usually needed in addition to reduction
of dietary salt intake. The fascinating insights into novel
pathomechanisms underlying salt-induced target organ
damage, e.g. cardiotonic steroids, may ultimately yield new
therapeutic interventions.
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